Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Olvi A OLVAS Mar 5, 2021 44.90 +1.13   
 Oma Säästöpankki OMASP Mar 5, 2021 11.00 +0.92   
 OMX Helsinki HEX Mar 5, 2021 11 078.00 -0.57   
 OMX Helsinki 25 OMXH25 Mar 5, 2021 4 765.13 -0.51   
 OMX Helsinki GI OMXHGI Mar 5, 2021 30 074.00 -0.55   
 OMX Helsinki Small Cap GI OMXHSCGI Mar 5, 2021 483.49 -0.95   
 Optomed OPTOMED Mar 5, 2021 5.73 -2.55   
 Oriola A OKDAV Mar 5, 2021 2.17 +0.93   
 Oriola B OKDBV Mar 5, 2021 2.00 0.00   
 Orion A ORNAV Mar 5, 2021 34.55 -0.14   
 Orion B ORNBV Mar 5, 2021 33.03 +0.33   
 Outokumpu OUT1V Mar 5, 2021 4.11 +0.93   
 Ovaro Kiinteistösijoitus OVARO Mar 5, 2021 3.92 -0.51   
 Panostaja PNA1V Mar 5, 2021 0.74 +2.48   
 Partnera OYJ PARTNE1 Mar 5, 2021 1.94 -0.77   
 Pihlajalinna PIHLIS Mar 5, 2021 10.80 0.00   
 PIIPPO PIIPPO Mar 5, 2021 3.66 -1.61   
 Ponsse PON1V Mar 5, 2021 33.30 -2.06   
 Privanet Group Oyj PRIVA Mar 5, 2021 0.47 +1.09   
 PunaMusta Media PUMU Mar 5, 2021 6.20 -1.59   
 QPR Software QPR1V Mar 5, 2021 2.02 -0.98   
 Qt Group QTCOM Mar 5, 2021 76.20 -4.03   
 Raisio K RAIKV Mar 5, 2021 3.63 -0.27   
 Raisio Vaihto-osake RAIVV Mar 5, 2021 3.69 +0.27   
 Rapala VMC RAP1V Mar 5, 2021 6.16 -1.28   
 Raute A RAUTE Mar 5, 2021 21.60 -0.46   
 Reka Industrial REKA Mar 5, 2021 3.48 +0.29   
 Remedy Entertainment Oyj REMEDY Mar 5, 2021 39.80 -2.21   
 Revenio Group REG1V Mar 5, 2021 50.80 -2.12   
 Robit ROBIT Mar 5, 2021 4.83 +1.68   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK